PACTR2010020001813440
Other
未知
EVALUATION OF THE SAFETY AND EFFICACY OF MEFLOQUINE AS INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA IN PREGNANCY IN HIV+ PATIENTS
FCRB0 sites0 target enrollmentDecember 23, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HIV/AIDS
- Sponsor
- FCRB
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Permanent resident in the area.
- •Gestational age at the first antenatal visit \< 28 weeks
- •HIV seropositive (after voluntary counseling and testing)
- •Indication to receive CTX prophylaxis (according to the national guidelines)
- •Signed informed consent
- •Agreement to deliver in the study site's maternity wards
Exclusion Criteria
- •Residence outside the study area or planning to move out in the following 10 months from enrollment
- •Gestational age at the first antenatal visit \> 28 weeks of pregnancy
- •Known history of allergy to CTX or MQ
- •Known history of severe renal, hepatic, psychiatric or neurological disease
- •MQ or halofantrine treatment in the preceding 4 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
EVALUATION OF THE SAFETY AND EFFICACY OF MEFLOQUINE AS INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA IN PREGNANCYPACTR2010020001429343FCRB
Completed
Not Applicable
The efficacy and safety of mefloquine in patients with progressive multifocal leukoencephalopathyJPRN-UMIN000022151Department of Neurology, Shimane University Hospital5
Active, not recruiting
Phase 1
Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay immunosuppression in comparison to current standard immunosuppression (mycophenolate mofetil, tacrolimus and continued corticosteroids) in renal transplantation. - UK ELiTERenal TransplantationMedDRA version: 7.1Level: PTClassification code 10038533EUCTR2004-005055-33-GBBarts and the London NHS Trust
Not yet recruiting
Phase 4
Evaluate the efficacy and safety of Artesunate-mefloquine (ASMQ) and low dose primaquine to treat uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Champasack province, Lao PDRMalariaACTRN12618001349235Ministry of Health120
Not yet recruiting
Not Applicable
Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritisJPRN-UMIN000003897Department of Infectious Diseases and Infection Control, Jikei University School of Medicine20